GKOS
USDGlaukos Corporation Common Stock
即時價格
價格圖表
關鍵指標
市場指標
開盤
$85.860
最高
$88.290
最低
$85.235
交易量
0.50M
公司基本面
市值
4.9B
行業
醫療器材
國家
United States
交易統計
平均交易量
1.05M
交易所
NYQ
貨幣
USD
52週範圍
相關新聞
Glaukos Announces Participation in Upcoming Investor Conferences
Glaukos Corporation (NYSE:GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced that its
JP Morgan Maintains Overweight on Glaukos, Raises Price Target to $120
JP Morgan analyst Allen Gong maintains Glaukos with a Overweight and raises the price target from $110 to $120.
Citigroup Maintains Buy on Glaukos, Raises Price Target to $113
Citigroup analyst Joanne Wuensch maintains Glaukos with a Buy and raises the price target from $110 to $113.
Wells Fargo Maintains Overweight on Glaukos, Raises Price Target to $122
Wells Fargo analyst Larry Biegelsen maintains Glaukos with a Overweight and raises the price target from $120 to $122.
Needham Maintains Buy on Glaukos, Raises Price Target to $117
Needham analyst David Saxon maintains Glaukos with a Buy and raises the price target from $115 to $117.
BTIG Maintains Buy on Glaukos, Raises Price Target to $116
BTIG analyst Ryan Zimmerman maintains Glaukos with a Buy and raises the price target from $104 to $116.
Glaukos Announces Third Quarter 2025 Financial Results
Glaukos Corporation (NYSE:GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases, today announced financial
